Skip to content

Eleven research sites. Two countries. One way of working.

Our Network

Panthera BioPartners brings together Panthera Clinical Research in the United Kingdom and Óbudai Egészségügyi Centrum (OEC) in Hungary. Sponsors get one partner across the UK MHRA and EU CTR regulatory routes. Patients get a clinic close to home, run to the same standards wherever they are.

One partner, two countries

Panthera now runs 11 research sites: seven in the United Kingdom and four in Hungary through OEC, which joined Panthera in April 2026.

If you are a patient in the UK, find your nearest UK clinic. If you are a sponsor or CRO, talk to our sponsor team.

Where we work

United Kingdom: 7 sites

Panthera Clinical Research runs community research clinics in Preston (head office), Glasgow, Rochdale, York, Sheffield, Keele and Enfield.

Therapeutic experience includes cardiovascular, MASH and fatty liver, C. diff, lipids, Alzheimer’s and vaccines.

View UK clinics

Hungary: 4 sites

Óbudai Egészségügyi Centrum (OEC) was founded in Budapest in 1997 and joined Panthera in April 2026. It runs clinical trials from Budapest (head office), Dunaújváros, Zalaegerszeg and Kaposvár.

Therapeutic experience includes diabetology, cardiology, nephrology, neurology, pulmonology, rheumatology, gastroenterology, dermatology and internal medicine.

Visit oec.hu (in Hungarian)

One sponsor team

Feasibility, contracting and start-up are run centrally for all eleven sites, so sponsors have one point of contact whether a study runs in the UK, Hungary or both.

Talk to our sponsor team

Why a two-country network matters to sponsors

Two regulatory routes, one contract

UK trials run under MHRA and HRA approval. Hungarian trials run under the EU Clinical Trials Regulation via CTIS and OGYÉI. Sponsors contract once with Panthera and gain both.

Broader, faster recruitment

Seven UK community sites and four Hungarian centres draw on distinct patient populations, with pre-screening databases in both countries.

Same quality model, everywhere

Shared SOPs, central feasibility and start-up, and one quality team, whichever country the patient walks into.

Planning a study in the UK or Hungary?

Tell us the indication, phase and countries you are considering and our sponsor team will come back to you.

Talk to our sponsor team